Serina Therapeutics (SER) Total Liabilities (2017 - 2026)
Serina Therapeutics (SER) posted Total Liabilities of $7.0 million for Q4 2025, down 35.41% sequentially from $10.8 million in Q3 2025, and up 12.42% YoY from $6.2 million in Q4 2024.
Serina Therapeutics (SER) Total Liabilities (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Total Liabilities for 9 years, with the latest figure at $7.0 million in Q4 2025.
- Quarterly Total Liabilities rose 12.42% year-over-year to $7.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.0 million (up 12.42% YoY) and the FY2025 annual result came in at $7.0 million, up 12.42% from the prior year.
- Total Liabilities slipped to $7.0 million in Q4 2025 per SER's latest filing, from $10.8 million in the prior quarter.
- Over five years, Total Liabilities peaked at $34.6 million in Q2 2023 and troughed at $3.9 million in Q3 2023.
- A 5-year average of $14.6 million and a median of $13.4 million in 2021 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities plunged 77.29% in 2023, then jumped 445.62% in 2024.
- Over 5 years, Total Liabilities stood at $15.0 million in 2021, then jumped by 36.78% to $20.6 million in 2022, then tumbled by 76.37% to $4.9 million in 2023, then increased by 27.95% to $6.2 million in 2024, then rose by 12.42% to $7.0 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $7.0 million, $10.8 million, and $7.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 10.03 Bn |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | 7.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.08 Mn |
| Dec 31, 2025 | 6.99 Mn |
| Sep 30, 2025 | 10.82 Mn |
| Jun 30, 2025 | 7.30 Mn |
| Mar 31, 2025 | 5.17 Mn |
| Dec 31, 2024 | 6.22 Mn |
| Sep 30, 2024 | 21.26 Mn |
| Jun 30, 2024 | 27.10 Mn |
| Mar 31, 2024 | 15.17 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Sep 30, 2023 | 3.90 Mn |
| Jun 30, 2023 | 34.57 Mn |
| Mar 31, 2023 | 32.54 Mn |
| Dec 31, 2022 | 20.56 Mn |
| Sep 30, 2022 | 17.16 Mn |
| Jun 30, 2022 | 15.84 Mn |
| Mar 31, 2022 | 14.31 Mn |
| Dec 31, 2021 | 15.03 Mn |
| Sep 30, 2021 | 12.41 Mn |
| Jun 30, 2021 | 10.84 Mn |